GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » FCF Yield %

D&D Pharmatech (XKRX:347850) FCF Yield % : -0.71 (As of Jun. 16, 2024)


View and export this data going back to 2024. Start your Free Trial

What is D&D Pharmatech FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, D&D Pharmatech's Trailing 12-Month Free Cash Flow is ₩-2,067 Mil, and Market Cap is ₩289,411 Mil. Therefore, D&D Pharmatech's FCF Yield % for today is -0.71%.

The historical rank and industry rank for D&D Pharmatech's FCF Yield % or its related term are showing as below:

XKRX:347850' s FCF Yield % Range Over the Past 10 Years
Min: -3.44   Med: -2.96   Max: -0.63
Current: -0.71


During the past 6 years, the highest FCF Yield % of D&D Pharmatech was -0.63%. The lowest was -3.44%. And the median was -2.96%.

XKRX:347850's FCF Yield % is ranked better than
83.63% of 1552 companies
in the Biotechnology industry
Industry Median: -13.865 vs XKRX:347850: -0.71

D&D Pharmatech's FCF Margin % for the quarter that ended in Dec. 2023 was -114.46%.


D&D Pharmatech FCF Yield % Historical Data

The historical data trend for D&D Pharmatech's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D&D Pharmatech FCF Yield % Chart

D&D Pharmatech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial - - - - -

D&D Pharmatech Quarterly Data
Dec22 Sep23 Dec23
FCF Yield % - - -

Competitive Comparison of D&D Pharmatech's FCF Yield %

For the Biotechnology subindustry, D&D Pharmatech's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


D&D Pharmatech's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, D&D Pharmatech's FCF Yield % distribution charts can be found below:

* The bar in red indicates where D&D Pharmatech's FCF Yield % falls into.



D&D Pharmatech FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

D&D Pharmatech's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-9162.629 / 0
=N/A%

D&D Pharmatech's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-2066.512 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


D&D Pharmatech FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


D&D Pharmatech FCF Yield % Related Terms

Thank you for viewing the detailed overview of D&D Pharmatech's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


D&D Pharmatech (XKRX:347850) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
4th floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Sampyeong-dong, I&C Building, Seongnam-si, KOR
D&D Pharmatech Inc is a company that comprises of experts in the field of bio-new drug research and development and technology commercialization, including basic scientists in the pharmaceutical biofield, manufacturing quality control (CMC) experts, and clinical development and technology transfer experts. Other business areas include the development of positron emission tomography (PET) imaging biomarkers conducted by Precision Molecular Inc. a 100% subsidiary, and single-cell sequencing related to degenerative brain diseases conducted by Valted Seq, Inc. The company utilizes drug delivery technologies such as PEGylation technology, which helps extend the administration interval using PEG and various chemicals, and platform technology that converts injectable drugs into oral preparations.

D&D Pharmatech (XKRX:347850) Headlines

No Headlines